Sculptra

Sculptra is a collagen-stimulating injectable that helps to smooth facial wrinkles and restore natural contours, achieving a flawless and youthful appearance. This treatment adds volume to areas like the chin and cheeks, where tissue loss has occurred, while also promoting the body’s collagen production for longer-lasting results.

Product Details

• Product Name: Sculptra Dermal Filler
• Product Keywords: Sculptra
• Type: 10 vials/box
• Color: White
• Specification: 150 mg/vial
• Shelf Life: 2 years
• Active Ingredient: Poly-L-lactic acid (PLLA)
• Application Areas: Face, body, and buttocks

Sculptra utilizes a natural method to replace lost facial collagen. It contains poly-L-lactic acid (PLLA), an alpha-hydroxy acid derived from the lactic acid family. PLLA is a synthetic polymer that has been safely used in surgical sutures for many years.

Indications for Use

Sculptra is a facial filler applicable for both cosmetic and medical purposes, including treatment for individuals with HIV experiencing facial volume loss. PLLA is both biocompatible and biodegradable.

The product is available in 367.5 mg strength vials that require reconstitution by adding 5 ml of sterile water for injection, resulting in a sterile, non-pyrogenic suspension.

Usage Instructions

Before injection, micro-particles of PLLA are mixed with sterile water. Sculptra is then injected beneath the skin, where it gradually degrades and stimulates collagen production. Over time, this results in increased volume in the treated areas. Patients can expect noticeable, natural improvements in their skin after two or three treatments, spaced 4 to 6 weeks apart. The results can last up to two years.

Safety Information and Precautions

When considering the purchase of Sculptra, it’s important to keep the following points in mind:

• If Sculptra is administered, subsequent treatments that induce an active dermal response (like laser resurfacing or chemical peeling) may lead to inflammatory reactions in the treated area.
• The safety and effectiveness of Sculptra have not been evaluated in areas without lipoatrophy or where other dermal fillers have been used.
• The application of Sculptra in the lips has not been adequately studied. Due to the red color of the vermillion area, injections in this region are discouraged.
• Sculptra should be injected deeply into the dermis or subcutaneous layer. Superficial injections may lead to adverse effects, such as papules and nodules, especially in the peri-orbital area. It should not be combined with other facial dermal fillers.
• Only a qualified medical practitioner familiar with the patient’s medical history and the product should administer Sculptra for the treatment of lipoatrophy in HIV patients.